Videos
State-of-the-industry video lectures by leading urology experts
Latest Videos
Featured Videos

CHICAGO, IL USA (UroToday.com) - Full Title: #ASCO14 - Poster: A randomized, open-label phase 2a study evaluating quantified bone scan response following treatment with radium-223 dichloride alone or in combination with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer who have bone metastases

Presented by Daniel Petrylak, MD,1 Julie A. Rosenberg, MD,2 Vittorio Luigi Garosi, MD, PhD,3 Jonathan Siegel,2 and Jonathan Goldin, MD4 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

asco 2014 petrylak poster thumb

Click HERE to listen to an exclusive interview with Daniel Petrylak, MD, one of the authors of the study

1Yale Cancer Center, New Haven, CT USA
2Bayer HealthCare Pharmaceuticals, Inc., Whippany NJ, USA
3Bayer S.p.A., Milan, Italy
4UCLA Radiology Science, Los Angeles, CA USA

 

Journals
Publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 3 Issue 2

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe

Calendar
Upcoming educational events
October 19-23, 2018 / European Society for Medical Oncology 2018 Congress
European Society for Medical Oncology 2018 Congress
October 19-20, 2018 / Hilton New York JFK Airport Hotel
16th International Conference on Nephrology & Therapeutics
October 19-20, 2018 / Hilton New York JFK Airport Hotel
3rd Annual Kidney Congress